Prokidney (PROK) Capital Expenditures (2021 - 2026)

Prokidney (PROK) has 6 years of Capital Expenditures data on file, last reported at $3.8 million in Q1 2026.

• Quarterly Capital Expenditures rose 233.48% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.8 million (down 39.88% YoY) and the FY2025 annual result came in at $15.2 million, down 48.5% from the prior year.
• Capital Expenditures slipped to $3.8 million in Q1 2026 per PROK's latest filing, from $5.8 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $27.9 million in Q3 2023 and bottomed at $306000.0 in Q4 2022.
• The 5-year median for Capital Expenditures is $1.6 million (2023), against an average of $5.0 million.
• The widest annual swing landed in 2023, when Capital Expenditures jumped 8769.52%; it then tumbled 91.4% in 2024.
• Tracing PROK's Capital Expenditures over 5 years: stood at $306000.0 in 2022, then surged by 413.73% to $1.6 million in 2023, then jumped by 1522.71% to $25.5 million in 2024, then plunged by 77.45% to $5.8 million in 2025, then slumped by 34.2% to $3.8 million in 2026.
• Per Business Quant, the three latest PROK Capital Expenditures figures stand at $3.8 million (Q1 2026), $5.8 million (Q4 2025), and $5.2 million (Q3 2025).

Peer Comparison